Can Mucosal Healing Be a Cost-effective Endpoint for Biologic Therapy in Crohnʼs Disease? A Decision Analysis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Can Mucosal Healing Be a Cost-effective Endpoint for Biologic Therapy in Crohnʼs Disease? A Decision Analysis
Authors
Keywords
-
Journal
INFLAMMATORY BOWEL DISEASES
Volume 19, Issue 1, Pages 37-44
Publisher
Oxford University Press (OUP)
Online
2012-03-14
DOI
10.1002/ibd.22951
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term Durability of Infliximab Treatment in Crohnʼs Disease and Efficacy of Dose “Escalation” in Patients Losing Response
- (2011) María Chaparro et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Health-economic analysis: cost-effectiveness of scheduled maintenance treatment with infliximab for Crohn’s disease - modelling outcomes in active luminal and fistulizing disease in adults
- (2010) J. LINDSAY et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A claims-based Markov model for Crohn’s disease
- (2010) D. C. Malone et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Endoscopic monitoring of infliximab therapy in Crohnʼs disease
- (2010) Clas-Göran af Björkesten et al. INFLAMMATORY BOWEL DISEASES
- Cost-Effectiveness of Computed Tomographic Colonography Screening for Colorectal Cancer in the Medicare Population
- (2010) Amy B. Knudsen et al. JNCI-Journal of the National Cancer Institute
- Cost-effectiveness of biological therapy for Crohn’s disease: Markov cohort analyses incorporating United Kingdom patient-level cost data
- (2009) K. BODGER et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Natural History of Adult Crohn's Disease in Population-Based Cohorts
- (2009) Laurent Peyrin-Biroulet et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review
- (2009) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohnʼs disease
- (2009) Geert R. DʼHaens et al. INFLAMMATORY BOWEL DISEASES
- Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease
- (2009) Fabian Schnitzler et al. INFLAMMATORY BOWEL DISEASES
- Clinical implications of mucosal healing for the management of IBD
- (2009) Guillaume Pineton de Chambrun et al. Nature Reviews Gastroenterology & Hepatology
- Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease
- (2008) Jennifer Jones et al. Clinical Gastroenterology and Hepatology
- Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM Study
- (2008) Brian G. Feagan et al. GASTROENTEROLOGY
- Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults
- (2008) Michael D. Kappelman et al. GASTROENTEROLOGY
- Does clinical response correlate with mucosal healing in patients with Crohnʼs disease of the small bowel? A prospective, case-series study using wireless capsule endoscopy
- (2008) Alkiviadis Efthymiou et al. INFLAMMATORY BOWEL DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started